170 related articles for article (PubMed ID: 8554592)
41. Gangliosides enhance migration of mouse B16-melanoma cells through artificial basement membrane alone or in presence of laminin or fibronectin.
Saha S; Mohanty KC; Mallick P
Indian J Exp Biol; 2005 Dec; 43(12):1130-8. PubMed ID: 16359123
[TBL] [Abstract][Full Text] [Related]
42. Structural characterization of the disialogangliosides of murine peritoneal macrophages.
Yohe HC; Ye S; Reinhold BB; Reinhold VN
Glycobiology; 1997 Dec; 7(8):1215-27. PubMed ID: 9455923
[TBL] [Abstract][Full Text] [Related]
43. Characterization of high-affinity binding between gangliosides and amyloid beta-protein.
Ariga T; Kobayashi K; Hasegawa A; Kiso M; Ishida H; Miyatake T
Arch Biochem Biophys; 2001 Apr; 388(2):225-30. PubMed ID: 11368158
[TBL] [Abstract][Full Text] [Related]
44. Isolation and characterization of extremely minor gangliosides, GM1b and GD1 alpha, in adult bovine brains as developmentally regulated antigens.
Hirabayashi Y; Hyogo A; Nakao T; Tsuchiya K; Suzuki Y; Matsumoto M; Kon K; Ando S
J Biol Chem; 1990 May; 265(14):8144-51. PubMed ID: 2186036
[TBL] [Abstract][Full Text] [Related]
45. Recombinant ganglioside GM2 synthase--expression in insect cells and enzyme assay.
Wendeler M; Reilaender H; Hoernschemeyer J; Schwarzmann G; Kolter T; Sandhoff K
Methods Enzymol; 2003; 363():476-89. PubMed ID: 14579597
[No Abstract] [Full Text] [Related]
46. Ganglioside biosynthesis in mouse embryos: sialyltransferase IV and the asialo pathway.
Seyfried TN; Novikov AM; Irvine RA; Brigande JV
J Lipid Res; 1994 Jun; 35(6):993-1001. PubMed ID: 8077855
[TBL] [Abstract][Full Text] [Related]
47. Reduced expression of gangliosides with GM2-determinant in cervical carcinoma-derived cells after subcutaneous transplantation into nude mice.
Tanaka K; Murakami I; Mikami M; Aoki D; Iwamori M
Hum Cell; 2023 May; 36(3):1199-1203. PubMed ID: 36932279
[TBL] [Abstract][Full Text] [Related]
48. Expression analysis of 0-series gangliosides in human cancer cell lines with monoclonal antibodies generated using knockout mice of ganglioside synthase genes.
Bhuiyan RH; Kondo Y; Yamaguchi T; Tokuda N; Ohkawa Y; Hashimoto N; Ohmi Y; Yamauchi Y; Furukawa K; Okajima T; Furukawa K
Glycobiology; 2016 Sep; 26(9):984-998. PubMed ID: 27102283
[TBL] [Abstract][Full Text] [Related]
49. Catabolism of asialo-GM2 in man and mouse. Specificity of human/mouse chimeric GM2 activator proteins.
Bertoni C; Li YT; Li SC
J Biol Chem; 1999 Oct; 274(40):28612-8. PubMed ID: 10497228
[TBL] [Abstract][Full Text] [Related]
50. Glycosyltransferase activities in cultured endothelial cells of bovine brain microvascular origin.
Kanda T; Ariga T; Yamawaki M; Yoshino H; Gu XB; Yu RK
Neurochem Res; 1997 Apr; 22(4):463-6. PubMed ID: 9130257
[TBL] [Abstract][Full Text] [Related]
51. Enhancement of metastatic potential of mouse B16-melanoma cells to lung after treatment with gangliosides of B-16-melanoma cells of higher metastatic potential to lung.
Saha S; Mohanty KC
Indian J Exp Biol; 2003 Nov; 41(11):1253-8. PubMed ID: 15332492
[TBL] [Abstract][Full Text] [Related]
52. Effects of gangliosides on the differentiation of human mesenchymal stem cells into osteoblasts by modulating epidermal growth factor receptors.
Kim SM; Jung JU; Ryu JS; Jin JW; Yang HJ; Ko K; You HK; Jung KY; Choo YK
Biochem Biophys Res Commun; 2008 Jul; 371(4):866-71. PubMed ID: 18471991
[TBL] [Abstract][Full Text] [Related]
53. Study on systematizing the synthesis of the a-series ganglioside glycans GT1a, GD1a, and GM1 using the newly developed N-Troc-protected GM3 and GalN intermediates.
Komori T; Imamura A; Ando H; Ishida H; Kiso M
Carbohydr Res; 2009 Aug; 344(12):1453-63. PubMed ID: 19560125
[TBL] [Abstract][Full Text] [Related]
54. Biosynthesis of conjugatable saccharidic moieties of GM2 and GM3 gangliosides by engineered E. coli.
Fort S; Birikaki L; Dubois MP; Antoine T; Samain E; Driguez H
Chem Commun (Camb); 2005 May; (20):2558-60. PubMed ID: 15900325
[TBL] [Abstract][Full Text] [Related]
55. Characteristic expression of GD1 alpha-ganglioside during lactation in murine mammary gland.
Momoeda M; Momoeda K; Takamizawa K; Matsuzawa A; Hanaoka K; Taketani Y; Iwamori M
Biochim Biophys Acta; 1995 May; 1256(2):151-6. PubMed ID: 7766692
[TBL] [Abstract][Full Text] [Related]
56. Glycosphingolipid glycosyltransferases in human fetal brain.
Percy AK; Gottfries J; Vilbergsson G; Månsson JE; Svennerholm L
J Neurochem; 1991 May; 56(5):1461-5. PubMed ID: 1901591
[TBL] [Abstract][Full Text] [Related]
57. Gangliotriaosylceramide (asialo GM2), a glycosphingolipid marker for cell lines derived from patients with Hodgkin's disease.
Kniep B; Monner DA; Burrichter H; Diehl V; Mühlradt PF
J Immunol; 1983 Sep; 131(3):1591-4. PubMed ID: 6886427
[TBL] [Abstract][Full Text] [Related]
58. Biosynthesis of monosulfogangliotriaosylceramide and GM2 by N-acetylgalactosaminyltransferase from rat brain.
Nagai K; Ishizuka I
J Biochem; 1987 May; 101(5):1115-27. PubMed ID: 3115968
[TBL] [Abstract][Full Text] [Related]
59. Modulation of ganglioside biosynthesis in primary cultured neurons.
van Echten G; Sandhoff K
J Neurochem; 1989 Jan; 52(1):207-14. PubMed ID: 2908888
[TBL] [Abstract][Full Text] [Related]
60. The ganglioside GD1 alpha' IV3Neu5Ac, III6Neu5Ac-GgOse4Cer, is a major disialoganglioside in the highly metastatic murine lymphoreticular tumour cell line MDAY-D2.
Müthing J; Peter-Katalinić J; Hanisch FG; Unland F; Lehmann J
Glycoconj J; 1994 Apr; 11(2):153-62. PubMed ID: 7804005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
